caffeine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

caffeine has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cowan, JO; Herbison, GP; Smith, AD; Taylor, DR; Taylor, ES1

Trials

1 trial(s) available for caffeine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma.
    American journal of respiratory and critical care medicine, 2004, May-01, Volume: 169, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bias; Breath Tests; Caffeine; Confounding Factors, Epidemiologic; Cross-Over Studies; Double-Blind Method; Feeding Behavior; Forced Expiratory Volume; Humans; Metabolic Clearance Rate; Middle Aged; Nitric Oxide; Sensitivity and Specificity; Time Factors

2004